Price Table
| Date | Open | High | Low | Close | Volume | Delivery % | 20-Day sma | 50-Day sma | 200-Day sma |
|---|
View More
Day High Low Range
| Time | Lowest | highest | Volume |
|---|
Past Performance & Moving Averages
| Day’s | Low high range | SMA | Stock performance | Nifty performance |
|---|
PIVOT POINTS
| NAME | S4 | S3 | S2 | S1 | PIVOT POINTS | R1 | R2 | R3 | R4 |
|---|---|---|---|---|---|---|---|---|---|
| CLASSIC | - | - | - | - | - | - | - | - | - |
| WOODIE‘S | - | - | - | - | |||||
| FIBONACCI | - | - | |||||||
| CAMARILLA | - |
Trend Analysis
Key Data
| Market cap | Book value | stock p/e | Dividend yield | roce | roe | sales growth (3Y) | face value (3Y) |
|---|
Profile
Alembic Pharmaceuticals
Founded: 1907
Headquarters: Vadodara, Gujarat
PROFILE
Indian Multinational Pharmaceutical Company involved in pharmaceutical substances and intermediates.
MANUFACTURING
Cough Syrups
Vitamin
Tonics
Sulfur Drugs
HISTORY
Started Manufacturing Tincture and Alcohol.
1960: Company entered into the production of Penicillin.
1961: Alembic plant for the manufacture of Penicillin was inaugurated by Lal Bahadur Shastri.
1961: Alembic soon imitated vitamin B12.
1971: Then started the production of Erythromycin.
1971: 'Althrocin' brand of erythromycin was incorporated.
2000: Company received ISO 14000 Certificate
2010: Alembic Paramautical demerged into Alembic
2007: The Company acquired the entire non-oncology formulation business of Dabur Pharma Ltd.
2012: The Company entered into product development and License agreement with AccuBreak Paramautical Ltd.
2013: To increase its market production entered into an out Licensing agreement with Ranbaxy Pharmaceutical Ltd.
2015: Expanded its market in Switzerland an exclusive agreement with Novartis.
AWARDS
2015: Top 50 Indian innovators.
2016: Super 50 Company of 2016.